However, in contrast to earlier findings, our data suggest that in del13q/NOTCH1wt CLL in vivo, valproate also transiently recruits EZH2 to the CD20 promoter corresponding to H3K27trimethylation and resistance to valproate-induced upregulation of CD20. Here, EZH2 is linked to B-cell chronic lymphocytic leukemia.